Literature DB >> 33650072

What Can the Chemical Hold?: The Politics of Efficacy in the Psychedelic Renaissance.

Katherine Hendy1.   

Abstract

Drawing from ethnographic research with psychedelic therapists and researchers, this article explores political tensions between two sources of efficacy within psychedelic therapy: the self and the chemical. At times researchers and therapists emphasize the specificity of chemical effects in relationship to the neurobiology of particular diagnoses. And at other times they foreground the self as the true source of an experience which is not tied to that same biochemistry. Anthropologists have long emphasized that efficacy is a historically and socially embedded category and practice. Those conversations have new valence in light of recent theorization of the chemicals as material-semiotic structures shaped by their experimental contexts. This article argues that while the empirical claims embedded in these two efficacies can and do mutually include each other, a fundamental political tension remains between the efficacious ends envisioned by each. As clinical trials develop these drugs as therapeutic agents, they do so through linking the specific effects of the chemical to particular diagnostic populations, which may enfranchise these chemicals, but not all their efficacies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Efficacy; Pharmaceuticals; Politics; Psychedelics; Science studies

Mesh:

Substances:

Year:  2021        PMID: 33650072      PMCID: PMC8875280          DOI: 10.1007/s11013-021-09708-7

Source DB:  PubMed          Journal:  Cult Med Psychiatry        ISSN: 0165-005X


  12 in total

1.  Cultural variations in the placebo effect: ulcers, anxiety, and blood pressure.

Authors:  D E Moerman
Journal:  Med Anthropol Q       Date:  2000-03

2.  The tyranny of diagnosis: specific entities and individual experience.

Authors:  Charles E Rosenberg
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

3.  Ayahuasca, psychedelic studies and health sciences: the politics of knowledge and inquiry into an Amazonian plant brew.

Authors:  Kenneth W Tupper; Beatriz C Labate
Journal:  Curr Drug Abuse Rev       Date:  2014

4.  "The same thing in a different box": similarity and difference in pharmaceutical sex hormone consumption and marketing.

Authors:  Emilia Sanabria
Journal:  Med Anthropol Q       Date:  2014-07-21

5.  Patients treated by physicians and folk healers: a comparative outcome study in Taiwan.

Authors:  A Kleinman; J L Gale
Journal:  Cult Med Psychiatry       Date:  1982-12

Review 6.  Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.

Authors:  Michael C Mithoefer; Charles S Grob; Timothy D Brewerton
Journal:  Lancet Psychiatry       Date:  2016-04-05       Impact factor: 27.083

7.  Methadone: six effects in search of a substance.

Authors:  Emilie Gomart
Journal:  Soc Stud Sci       Date:  2002-02       Impact factor: 3.885

8.  The efficacy and self-efficacy of treatment: ethnomedical aspirations, biomedical inhibitions, and health outcomes.

Authors:  Mike Poltorak
Journal:  Med Anthropol Q       Date:  2013-06-19

9.  MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials.

Authors:  Katherine Hendy
Journal:  Med Anthropol Q       Date:  2020-05-18

10.  Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.

Authors:  Linnae Ponte; Lisa Jerome; Scott Hamilton; Michael C Mithoefer; Berra B Yazar-Klosinski; Eric Vermetten; Allison A Feduccia
Journal:  J Trauma Stress       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.